🔎 Trials Near Me

Home › Sakit ng Graft-versus-Host › Massachusetts

Pag-aaral pangklinika para sa Sakit ng Graft-versus-Host sa Massachusetts

10 pag-aaral para sa Sakit ng Graft-versus-Host ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

  • Massachusetts General Hospital, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06910969

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 2 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06991361

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  • Massachusetts General Hospital, Boston
Nagre-recruitPhase 2
Edad 2 pataas · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT04710576

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT06615050

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

  • Boston Children's Hospital, Boston
Nagre-recruitPhase 2
Edad 2 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT04380740

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT05236062

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06619561

IS-free Treg HaploHCT

  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT04678401

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

  • Dana Farber, Boston
Nagre-recruitObservasyonal na pag-aaral
36 Months · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT05866302

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2025 · NCT06462365

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.